ENTERO logo

Entero Healthcare Solutions Limited Stock Price

NSEI:ENTERO Community·₹49.4b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

ENTERO Share Price Performance

₹0
-1201.90 (-100.00%)
₹1,410.50
Fair Value
₹0
-1201.90 (-100.00%)
Price ₹0

ENTERO Community Narratives

·
Fair Value ₹1.41k 19.5% undervalued intrinsic discount

India Urbanization And Market Consolidation Will Expand Pharma Distribution

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
₹1.41k
19.5% undervalued intrinsic discount
Revenue
24.17% p.a.
Profit Margin
2.76%
Future PE
27.17x
Price in 2029
₹1.98k

Trending Discussion

Updated Narratives

ENTERO logo

ENTERO: Board Decisions And Option Grants Will Shape A Balanced Outlook

Fair Value: ₹1.41k 19.5% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with reasonable growth potential.

0 Risks
4 Rewards

Entero Healthcare Solutions Limited Key Details

₹65.9b

Revenue

₹59.1b

Cost of Revenue

₹6.8b

Gross Profit

₹5.7b

Other Expenses

₹1.2b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
26.44
10.32%
1.75%
32.3%
View Full Analysis

About ENTERO

Founded
2018
Employees
4111
CEO
Prabhat Agrawal
WebsiteView website
www.enterohealthcare.com

Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices, such as orthopaedic implants and coronary stents, and hospital consumables comprising examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.

Recent ENTERO News & Updates

Analysis Article May 28

Entero Healthcare Solutions Limited Just Missed Earnings - But Analysts Have Updated Their Models

Shareholders might have noticed that Entero Healthcare Solutions Limited ( NSE:ENTERO ) filed its yearly result this...

Recent updates

No updates